Article info
PDFLetter to the Editor
Device manufacturer’s response to ‘Author’s response to Durbin reply concerning safety issue with TT380 Slimline intrauterine device and the new modified device’
- Correspondence to Dr Charles-Dominique Lafont, Laboratoire 7 MED, Le Bioparc, Hauterive 03270, France; 7medindustrie{at}wanadoo.fr
Citation
Device manufacturer’s response to ‘Author’s response to Durbin reply concerning safety issue with TT380 Slimline intrauterine device and the new modified device’
Publication history
- Received November 1, 2017
- Accepted November 7, 2017
- First published December 29, 2017.
Online issue publication
November 20, 2018
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.